NASDAQ
Astria Therapeutics, Inc. (ATXS) has a current ratio of 17.49x as of Monday, May 25, 2026. This represents a 10.90% decrease compared to its 12-month average of 19.63x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.